1-cyano-benzocyclobutene | 117917-37-0

• 分子结构分类: 有机化合物 - 苯类化合物
• 英文名称: 1-cyano-benzocyclobutene
• 英文别名: cyanobenzocyclobutene；Bicyclo[4.2.0]octa-1,3,5,7-tetraene-7-carbonitrile；bicyclo[4.2.0]octa-1(8),2,4,6-tetraene-7-carbonitrile
• CAS: 117917-37-0
• 化学式: C₉H₅N
• 分子量: 127.145
• InChiKey: HZTDUTYUVZYCSB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-cyano-benzocyclobutene 在 sodium nitrate 、 硫酸 、 碳酸氢钠 作用下， 以 二氯甲烷 、 水 为溶剂， 以64.1%的产率得到5-nitro-1-cyanobenzocyclobutene
  参考文献：
  名称：

  N-Substituted arylcyclo butenyl-maleimides

  摘要：

  该发明涉及一种化合物，其包括不饱和环酰亚胺基团和芳基环丁烯基团，其中环丁烯基团与芳基基团融合，且亚胺氮原子通过直接键或桥联成员连接到芳基基团。该发明的另一个方面是由上述化合物聚合而成的聚酰亚胺聚合物组成。

  公开号：

  US04826997A1
• 作为产物：
  描述：

  (E)-3-(2-chlorophenyl)-2-propenenitrile 生成 1-cyano-benzocyclobutene
  参考文献：
  名称：

  KIRCHOFF, R. A.

  摘要：

  DOI：

文献信息

• Novel poly(arylcyclobutenes)
  申请人：The Dow Chemical Company

  公开号：US04999449A1

  公开（公告）日：1991-03-12

  The invention is a poly(arylcyclobutene) comprising arylcyclobutene moieties connected by a bridging member, which comprises a polyvalent organic radical which comprises carbonyloxy moieties which are bound to each aryl moiety, and a hydrocarbon poly-yl optionally containing N, O, S or P, wherein each carbonyloxy moiety is bound to such poly-yl, and wherein one or more cyclobutene rings are fused to one of the aryl rings.

  这项发明是一种聚(芳基环丁烯)，包括由桥接成员连接的芳基环丁烯基团，该桥接成员包括包含与每个芳基基团结合的羰氧基团的多价有机基团，以及一个含有N、O、S或P的碳氢基团，其中每个羰氧基团与这样的碳氢基团结合，且一个或多个环丁烯环与其中一个芳基环融合。
• Arylcyclobutene monomers and polymers
  申请人：THE DOW CHEMICAL COMPANY (a Delaware corporation)

  公开号：EP0527508A3

  公开（公告）日：1995-05-17

  Novel arylcyclobutene monomers contain a single arylcyclobutene moiety and a maleimide or an a-ethylenically unsaturated hydrocarbon group which is directly bonded to the aryl group of the arylcyclobutene. Preferably, the arylcyclobutene moiety is benzocyclobutene and particularly preferred monomers are those correspond to the Formula II: wherein B is maleimide or an a-ethylenically unsaturated hydrocarbon group and R is separately in each occurrence hydrogen or cyano.

  新颖的芳基环丁烯单体包含一个芳基环丁烯基团和一个马来酰亚胺或直接与芳基环丁烯基团相结合的α-乙烯不饱和碳氢基团。最好的情况是，芳基环丁烯基团是苯环丁烯，特别偏好的单体是符合以下式II的那些：其中B是马来酰亚胺或α-乙烯不饱和碳氢基团，R在每次出现时分别为氢或氰基。
• Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines
  申请人：American Home Products Corporation

  公开号：US20020091273A1

  公开（公告）日：2002-07-11

  This invention relates to a method for the regioselective synthesis of 4,6,7,8-substituted benzo[g]quinoline-3-carbonitriles and 4,6,7,8-substituted benzo[g]quinazolines as well as intermediates thereof. The compounds derived from this invention are useful for the treatment of a variety of diseases that are a result of deregulation of these PTK's, and more specifically, are anti-cancer agents and are useful for the treatment of cancer in mammals. In addition, the compounds derived from this invention are useful for the treatment of polycystic kidney disease in mammals.

  该发明涉及一种用于选择性合成4,6,7,8-取代苯并[g]喹啉-3-碳腈和4,6,7,8-取代苯并[g]喹唑啉以及它们的中间体的方法。该发明衍生的化合物可用于治疗由这些PTK的失调导致的各种疾病，更具体地说，它们是抗癌剂，可用于治疗哺乳动物的癌症。此外，该发明衍生的化合物可用于治疗哺乳动物的多囊肾病。
• Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
  申请人：Berger Maarten Dan

  公开号：US20060041127A1

  公开（公告）日：2006-02-23

  This invention relates to a method for the regioselective synthesis of 4,6,7,8-substituted benzo[g]quinoline-3-carbonitriles and 4,6,7,8-substituted benzo[g]quinazolines as well as intermediates thereof. The compounds derived from this invention are useful for the treatment of a variety of diseases that are a result of deregulation of these PTK's, and more specifically, are anti-cancer agents and are useful for the treatment of cancer in mammals. In addition, the compounds derived from this invention are useful for the treatment of polycystic kidney disease in mammals.

  本发明涉及一种4,6,7,8-取代苯并[g]喹啉-3-羧腈和4,6,7,8-取代苯并[g]喹唑啉的区域选择性合成方法及其中间体。本发明所得化合物可用于治疗多种疾病，这些疾病是由这些PTK的失调所致，更具体地说，它们是抗癌剂，可用于治疗哺乳动物的癌症。此外，本发明所得化合物还可用于治疗哺乳动物的多囊肾病。
• Platinum complexes with mononitrile-containing ligands
  申请人：Xiao Zejun

  公开号：US20070173485A1

  公开（公告）日：2007-07-26

  Disclosed herein are novel platinum-based complexes possessing one nitrile substituent group (mononitrile) covalently-bonded to the platinum, one or more nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA and leaving groups (i.e., L 1 and L 2 )which can be hydrolyzed iii vivo to active species, which can then form coordinate adducts with DNA or RNA at the Guanine or Adenine bases thereof. Also disclosed herein are the reaction schemes for the synthesis of said platinum complexes, as well as methods of treatment of various types of cancer by the administration of a pharmaceutically-effective dose of said novel platinum complexes.

  本文披露了一种新型铂基配合物，其具有一个腈基取代基（单腈基）与铂共价键结合，一种或多种氮供体配体能够与DNA或RNA中的碱基形成氢键，以及可在体内水解为活性物种的离去基（即L1和L2），该活性物种随后可以与DNA或RNA的鸟嘌呤或腺嘌呤碱基形成配位加合物。本文还披露了合成所述铂配合物的反应方案，以及通过给予所述新型铂配合物的药物有效剂量治疗各种癌症的方法。